Mukka Proteins to hold 15th AGM on September 18, 2025, via video conferencing
The announcement is a standard regulatory disclosure about the scheduling of the AGM, which is a routine corporate governance event and typically has minimal direct market impact.
The announcement is a routine compliance update regarding the scheduling of the company's Annual General Meeting, which does not inherently indicate positive or negative financial or operational changes.
* Mukka Proteins Limited will hold its 15th Annual General Meeting (AGM) for the financial year 2024-25 on Thursday, 18th September 2025, at 3:00 p.m. (IST). * The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). * The Notice of AGM and the Annual Report for the financial year 2024-25 will be sent to the members in due course.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.